Old Web
English
Sign In
Acemap
>
Paper
>
OUTCOMES AFTER FIRST‐LINE IMMUNOCHEMOTHERAPY FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS: A LYSA STUDY
OUTCOMES AFTER FIRST‐LINE IMMUNOCHEMOTHERAPY FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS: A LYSA STUDY
2021
Vincent Camus
Cédric Rossi
Pierre Sesques
J. Lequesne
D. Tonnelet
Corinne Haioun
Éric Durot
A. Willaume
M Gauthier
Marie‐P. Moles‐Moreau
C. Antier
Julien Lazarovici
H. Monjanel
Sophie Bernard
M. Tardy
Caroline Besson
Laure Lebras
Sylvain Choquet
K. Le Du
Christophe Bonnet
Sarah Bailly
Ghandi Damaj
Kamel Laribi
Hervé Maisonneuve
Roch Houot
Adrien Chauchet
Fabrice Jardin
Alexandra Traverse-Glehen
P. Decazes
Stéphanie Becker
A. Berriolo‐Riedinger
H. Tilly
Keywords:
Internal medicine
first line
Primary mediastinal B-cell lymphoma
Medicine
Oncology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]